Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.
about
Human growth hormone doping in sportThe Role of the Multiple Hormonal Dysregulation in the Onset of "Anemia of Aging": Focus on Testosterone, IGF-1, and Thyroid HormonesGrowth hormone in the aging maleNeuroendocrine control of GH release during acute aerobic exercise.Testosterone supplementation in older men restrains insulin-like growth factor's dose-dependent feedback inhibition of pulsatile growth hormone secretion.Theodore R. Woodward Award. Age-related decline in growth hormone secretion: clinical significance and potential reversibility.Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrationsInfluence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applicationsOlder males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger malesHormone replacement therapy and physical function in healthy older men. Time to talk hormones?Human insulin/IGF-1 and familial longevity at middle age.Epigenetic characterization of the growth hormone gene identifies SmcHD1 as a regulator of autosomal gene clusters.Anti-Aging Potentials of Methylene Blue for Human Skin Longevity.Testosterone therapy in men: clinical and pharmacological perspectives.Update on endocrine disturbances in anorexia nervosa.Growth hormone pulsatility profile characteristics following acute heavy resistance exercise.Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiencyLow protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population.Managing the transition of adolescents with GH deficiency.Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.Overweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency.Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.Muscle wasting and cachexia in heart failure: mechanisms and therapies.Hormonal regulators of muscle and metabolism in aging (HORMA): design and conduct of a complex, double masked multicenter trial.Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factorEffects of growth hormone administration in human obesity.Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies.GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90The relationship between reduced testosterone, stimulated growth hormone secretion and increased carotid intima-media thickness in obese menThyroxine modifies the effects of growth hormone in Ames dwarf mice.Ageing, growth hormone and physical performance.Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult MiceHormonal regulation of longevity in mammals.Causes and consequences of obesity: epigenetics or hypokinesis?Physiological and pathological growth hormone secretion.Diagnosing growth hormone deficiency in adults.Provocative stimulation of growth hormone: a monozygotic twin study discordant for spinal cord injury.Cardiovascular risk in aging and obesity: is there a role for GH.Effects of gender, body weight, and blood glucose dynamics on the growth hormone response to the glucagon stimulation test in patients with pituitary disease.
P2860
Q24656056-FA905DB1-9380-4220-9C58-C37EB2779B12Q26771431-AA67E4B1-1A8D-4819-B4D0-00DEC5738840Q27024785-F5C3BC10-0DBF-490E-8A9A-D43FAD3E33C3Q30312103-B8B946AD-BFF5-47D2-9F52-B3B625878817Q30437490-D9300E24-32DA-4182-8193-74A18431395AQ30441734-9D65BFD4-B328-4DA6-813A-9862A34A81C1Q30447872-890F59C8-7C83-4B6A-9246-FCCBC0EF1FDEQ30449301-D631F7AF-DC91-4A7B-B443-C4D559EF85CAQ30454450-314059F2-56FF-413C-9FC6-12684CA95299Q33569163-9C361683-CF4F-4774-9351-A60E4BB7B8EDQ33588794-53786FCB-E2CF-4125-B0CD-DED0900DEDCCQ33599586-8363E58C-8203-4FF0-8CFD-008EB459002DQ33740320-2C8F5470-3FAB-4C29-A148-20F9E6828D24Q33913912-5B0EA130-25C5-47FB-92C6-2F49A14F8204Q33950114-A7250852-D8D0-45E2-A2A8-31836D04E993Q33951630-C5CF22B6-6395-4D6F-B681-61F02B90BD86Q33958289-BD639EFA-5F4D-4FFB-B480-6A35E56A85D3Q34396589-308AB7B9-7EC8-46FE-BE19-919A783E945BQ34408943-335C2F1F-B681-4123-ADB6-FE7BCDA22BD3Q34444314-B17BDFD2-1E4A-4458-A6A0-6CAEB5F5DDA3Q34571826-99FB49CE-9B70-4C6C-A6F7-BEEE2A30DE53Q34628461-CC5A01CD-BFF0-4027-8716-C8FAE0519E26Q34643136-2D8E4E65-CD61-4C8B-86A9-67EF8E1CF1ECQ34681621-E1E26B0A-97FD-46F8-ABF9-DCA59CB62E5CQ34993450-03D727A8-61EF-4AA6-8E51-951838CBE522Q35038082-70AF95F4-664B-4113-9847-7F32A5EC17E2Q35064726-613DB2CA-AB48-4DFD-9BFB-87E847A493F7Q35072510-B007F88F-6FF7-40EC-9A91-C0EB836CC40EQ35103887-0D2A3787-93B2-47F3-AC97-E5330BEFCF8BQ35578278-32CB8407-8D53-4660-AFFF-D87BC0A2A69FQ35598549-22F67CD7-CD0D-4A6C-AFE4-9B14CEED71F1Q35667556-AC03777A-10B7-4953-B428-D8F0E2A107B9Q35973894-8D8A02A2-9E29-4D51-B606-00075ABF1525Q35994796-575A767F-FB54-4B80-9E19-A5565D08DBCDQ36079417-74500B45-B435-4A8C-B618-E2969858852BQ36103782-1BAE3B09-6DF4-4530-9E8B-7B518B754B5CQ36140969-31593079-45F2-4D4D-8248-7FC72828C097Q36276625-09D5E135-E36D-46AF-80AF-D97158439C33Q36309188-28CCDC89-906B-44A5-887B-F9CE46D86CC2Q36473060-85A1B60F-6192-48C3-AA8E-17C4F026056C
P2860
Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Age and relative adiposity are ...... endogenous GH in healthy men.
@en
Age and relative adiposity are ...... nd amplitude of growth hormone
@nl
type
label
Age and relative adiposity are ...... endogenous GH in healthy men.
@en
Age and relative adiposity are ...... nd amplitude of growth hormone
@nl
prefLabel
Age and relative adiposity are ...... endogenous GH in healthy men.
@en
Age and relative adiposity are ...... nd amplitude of growth hormone
@nl
P356
P1476
Age and relative adiposity are ...... endogenous GH in healthy men.
@en
P2093
Iranmanesh A
Lizarralde G
P304
P356
10.1210/JCEM-73-5-1081
P407
P577
1991-11-01T00:00:00Z